Night blindness, congenital stationary
|
0.730 |
GermlineCausalMutation
|
disease |
ORPHANET |
GNAT1 associated with autosomal recessive congenital stationary night blindness.
|
22190596 |
2012 |
Night blindness, congenital stationary
|
0.730 |
GermlineCausalMutation
|
disease |
ORPHANET |
Missense mutation in the gene encoding the alpha subunit of rod transducin in the Nougaret form of congenital stationary night blindness.
|
8673138 |
1996 |
Night Blindness, Congenital Stationary, Autosomal Dominant 3
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1G
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Neoplasms
|
0.020 |
AlteredExpression
|
group |
BEFREE |
We have demonstrated in this study that a novel lncRNA, lnc-GNAT1-1, is low expressed in colorectal cancer tissues and plasma, and acts as a tumor suppressor through regulating RKIP-NF-κB-Snail circuit.
|
27912775 |
2016 |
Malignant neoplasm of stomach
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Lnc‑GNAT1‑1 overexpression inhibited gastric cancer cell migration and invasion.
|
30132541 |
2018 |
Secondary malignant neoplasm of liver
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Expression of lnc-GNAT1-1 was decreased in liver metastasis than the primary tumor, while the later one is lower than the paired normal mucosa.
|
27912775 |
2016 |
Stomach Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Lnc‑GNAT1‑1 overexpression inhibited gastric cancer cell migration and invasion.
|
30132541 |
2018 |
Tumor Cell Invasion
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
Lnc‑GNAT1‑1 overexpression inhibited gastric cancer cell migration and invasion.
|
30132541 |
2018 |
Night blindness, congenital stationary
|
0.730 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Night blindness, congenital stationary
|
0.730 |
Biomarker
|
disease |
HPO |
|
|
|
Night blindness, congenital stationary
|
0.730 |
Biomarker
|
disease |
CTD_human |
|
|
|
Night Blindness, Congenital Stationary, Autosomal Dominant 3
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Night Blindness, Congenital Stationary, Autosomal Dominant 3
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Night Blindness, Congenital Stationary, Autosomal Dominant 3
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1G
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Disorder of eye
|
0.300 |
Biomarker
|
group |
GENOMICS_ENGLAND |
|
|
|
Disorder of eye
|
0.300 |
Biomarker
|
group |
GENOMICS_ENGLAND |
|
|
|
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B (disorder)
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Night Blindness, Congenital Stationary, Type 1A
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Night blindness, congenital stationary, type 1
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
X-Linked Csnb
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Cone-rod synaptic disorder, congenital nonprogressive
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|